Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2016 Jun 1;73(6):632-5.
doi: 10.1001/jamaneurol.2016.0576.

Cerebral Microbleeds and Thrombolysis: Clinical Consequences and Mechanistic Implications

Affiliations
Editorial

Cerebral Microbleeds and Thrombolysis: Clinical Consequences and Mechanistic Implications

Mark Fisher. JAMA Neurol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Fisher receives research grant support from Otsuka Pharmaceutical Company and Boehringer-Ingelheim and is a member of clinical events committees of Covidien.

Figures

Figure
Figure. A Vascular Neurobiology Model of Cerebral Microbleeds
In this model of cerebral microbleeds, the 4 principal vascular comorbidities (hypertension, cerebral amyloid angiopathy, chronic kidney disease, and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy [CADASIL]) all affect brain arterioles. The consequences are impaired autoregulation (dysfunctional regulation of cerebral blood flow) producing incapacity to accommodate alterations in systemic blood pressure. Further arteriolar injury, ie, necrosis occurring spontaneously or induced by ischemia, results in intracerebral hemorrhage. Concurrently, blood-brain barrier alterations owing to aging, hypertension, cerebral amyloid angiopathy, CADASIL, and possibly chronic kidney disease, create the impaired capillary bed needed for red blood cell extravasation and development of microhemorrhage, the pathologic substrate of microbleeds.

Comment on

References

    1. Fisher M. Cerebral microbleeds: where are we now? Neurology. 2014;83(15):1304–1305. - PubMed
    1. Tsivgoulis G, Zand R, Katsanos AH, et al. Risk of symptomatic intracerebral hemorrhage after intravenous thrombolysis in patients with acute ischemic stroke and high cerebral microbleed burden: a meta-analysis [published online April 18, 2016] JAMA Neurol. doi: 10.1001/jamaneurol.2016.0292. - DOI - PubMed
    1. Jickling GC, Liu D, Stamova B, et al. Hemorrhagic transformation after ischemic stroke in animals and humans. J Cereb Blood Flow Metab. 2014;34(2):185–199. - PMC - PubMed
    1. Greenberg SM, Vernooij MW, Cordonnier C, et al. Microbleed Study Group. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009;8(2):165–174. - PMC - PubMed
    1. Fisher MJ. Brain regulation of thrombosis and hemostasis: from theory to practice. Stroke. 2013;44(11):3275–3285. - PMC - PubMed